Evolent Health (EVH) Tops Q4 EPS by 16c

Evolent Health (NYSE: EVH) reported Q4 EPS of ($0.05), $0.16 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $46.1 million versus the consensus estimate of $43.73 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• King Slide Works Co Ltd (2059:TT) PT Raised to NT$12,000 at Goldman Sachs
• Mizuho Reiterates Neutral Rating on Bloom Energy Corp. (BE)